Jianming Guo

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Tyrosine Kinase

Mesenchymal Stem Cells

Endoscopic Submucosal Dissection

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jiajun Wang, Sihong Zhang, Ying Wang, Yanjun Zhu, Xianglai Xu, Jianming Guo
Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma. Cancer medicine 13 (7) (2024)
Jiajun Wang, Sihong Zhang, Ying Wang, Yanjun Zhu, Xianglai Xu, Jianming Guo
Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma. Cancer medicine 13 (7) (2024)
Xianglai Xu, Sihong Zhang, Ying Wang, Yanjun Zhu, Jiajun Wang, Jianming Guo
HMOX1 pathway signature predicts clinical benefit from immunotherapy plus tyrosine kinase inhibitor therapy in advanced renal cell carcinoma. Cancer medicine (2023)
Ruopeng Su, Liangren Liu, Daoping Hong, Shuai Jiang, Yichu Yuan, Xingyun Cai, Hai-Long Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Jian Huang, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Minfeng Chen, Qiang Wei, Jiwei Huang, Wei Xue
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study. Cancer medicine (2023)
Sujun Han, Zhigang Ji, Junhui Jiang, Xinrong Fan, Qi Ma, Linjun Hu, Wen Zhang, Hao Ping, Jiansong Wang, Wanhai Xu, Benkang Shi, Wei Wang, Haifeng Wang, Honglei Wang, Shouzhen Chen, Hailong Hu, Jianming Guo, Shen Zhang, Shuai Jiang, Quan Zhou, Nian-Zeng Xing
Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 study. Cancer medicine (2023)
Chenyang Xu, Shuai Jiang, Lujia Zou, Lu Sheng, Guowei Shi, Bin Xu, Zhong Wang, Danfeng Xu, Xin Xie, Jianfeng Luo, Jianming Guo, Haowen Jiang
Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial. Cancer (2022)